[Home]   [Full version]  

Researchers demonstrate how white blood cells cannibalize virus-infected cells

Oct 02 ,Medicine & Health


Researchers at the Vaccine and Gene Therapy Institute (VGTI) at Oregon Health & Science University have demonstrated how certain white blood cells literally eat virus-infected cells while fighting disease at the microscopic level. The research not only helps provide a clearer understanding of the body's immune system, it also offers hope of a new method for gauging vaccine effectiveness. The research is published in the current edition of the journal Nature Medicine.

CD8+ T-cells are specialized white blood cells that serve an important role in the body's immune system. The cells attack and destroy disease "invaders" such as viruses in the body. Previous studies indicated that T-cells may consume parts of cells with which they interact, but this new research shows this can happen in response to a systemic viral infection.

"If you use a fluorescent dye to stain infected cells, you can literally watch T-cells consume membranes and outer surfaces of diseased cells. As they destroy and cannibalize the fluorescently labeled cells, they become labeled with the fluorescent dye themselves," explained Mark Slifka, Ph.D., a researcher in the VGTI who led the research. Slifka is also a scientist in the Division of Pathobiology and Immunology at the Oregon National Primate Research Center and holds a concurrent appointment in the Department of Molecular Microbiology and Immunology in the OHSU School of Medicine.

"While we don't fully understand why this happens, one possibility is that the T-cell consumes virus-infected cells to fuel itself in the continued fight against an ongoing infection. It's sort of like invaders that pillage their defeated foe's supplies and then continue the fight."

The way in which Slifka and his colleague, Carol Beadling, made this discovery was quite serendipitous. The researchers were studying the interactions between virus-specific T-cells and fluorescently labeled infected cells when they noticed that the T-cells also began to glow with the fluorescent dye. Further investigation revealed that the CD8+ T-cells, often referred to as "killer" T-cells, were literally ingesting parts of the virus-infected cells that they were attacking.

Slifka and Beadling's findings follow a discovery by David Parker, Ph.D., a professor of Molecular Microbiology and Immunology in the OHSU School of Medicine. Parker and his colleague, Scott Wetzel, noted a similar behavior in CD4+ T-cells, often called "helper" T-cells, which are less aggressive T-cells but also an important aspect of the immune system.

"Another interesting finding for our lab is that in some ways, T-cells can be picky eaters," explained Slifka. "Although they will destroy almost any infected cell, they prefer to eat certain types of cells but not others. For instance, we noted that CD8+ T-cells consumed other white blood cells such as infected B-cells, but they were not fond of eating infected fibroblasts, a type of cell found in connective tissue. They're sort of like a 5-year-old who loves to eat cookies, but refuses to eat their brussels sprouts."

The researchers believe that these findings may be useful as a method for determining a vaccine's effectiveness during the process of immunization. Measuring the levels at which CD8+ T-cells respond to and consume a candidate vaccine could likely determine whether that vaccine is effective in educating the body's immune system as to what diseases to look for.

Source: Oregon Health & Science University

Related stories:

Scientists film inner workings of the immune system
Forget what's number one at the box office this week. The most exciting new film features the intricate workings of the body, filmed by scientists using ground-breaking technology.
Study sheds light on causes of HIV dementia
A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications. The finding, published in Journal of Neuroscience, highlights a new target for drugs that could prevent HIV-associated dementia, an incurable and increasingly common complication in people with AIDS. Even with anti-retroviral drug therapies, up to one-half of people infected with HIV will develop mild to moderate neurological complications, according to some estimates.
Researchers identify cell group key to Lyme disease arthritis
A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease.
Interferon needed for cells to 'remember' how to defeat a virus
Scientists at UT Southwestern Medical Center have determined that the immune-system protein interferon plays a key role in "teaching" the immune system how to fight off repeated infections of the same virus.
Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses. Research to be presented at the 57th American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting in New Orleans, explains how vaccines and drugs may not only be able to stop disease transmission, but also prematurely kill the vectors carrying these diseases; such vectors include ticks, sand flies and mosquitoes – the insects responsible for most deaths world wide.
Discovery of virus in lemur could shed light on AIDS
The genome of a squirrel-sized, saucer-eyed lemur from Madagascar may help scientists understand how HIV-like viruses coevolved with primates, according to new research from the Stanford University School of Medicine. The discovery, to be published online on Dec. 1 in the Proceedings of the National Academy of Sciences, could provide insight into why non-human primates don't get AIDS and lead to treatments for humans.
Immune cells reveal fancy footwork
Our immune system plays an essential role in protecting us from diseases, but how does it do this exactly? Dutch biologist Suzanne van Helden discovered that before dendritic cells move to the lymph nodes they lose their sticky feet. This helps them to move much faster. Immature dendritic cells patrol the tissues in search of antigens. After exposure to such antigens they undergo a rigorous maturation process. During this maturation the dendritic cells migrate to the lymph nodes to activate T cells. Suzanne van Helden studied the adhesion and migration of both immature and mature dendritic cells.
Scientists find key to keeping killer T cells in prime shape for fighting infection, cancer
Like tuning a violin to produce strong, elegant notes, researchers at The Wistar Institute have found multiple receptors on the outside of the body's killer immune system cells which they believe can be selectively targeted to keep the cells in superb infection- and disease-fighting condition.

News discussion:

Medicine & Health news

[Home]   [Full version]